Brief News: Although there are improvements in the fourth quarter data, JXR's annual business still fell by 1.4%
I'm PortAI, I can summarize articles.
JXR released data showing that the number of in vitro fertilization (IVF) treatments in the fourth quarter of 2025 was 7,004, an increase of 12% year-on-year. Despite a strong performance in the fourth quarter, the total number of IVF treatments for the year still declined by 1.4% to 28,039. The IVF treatments at the Chengdu flagship center rose by 1.3% to 14,070, while overseas business fell by 6.9% to 4,235. On Tuesday, the stock price slightly increased to HKD 2.50, down about 5% over the past 52 weeks
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: BambooWorks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments